Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)
Price and Volume
Detailed Quote| Volume | 1,867,338 |
| Open | 33.40 |
| Bid (Size) | 31.79 (100) |
| Ask (Size) | 32.50 (1,000) |
| Prev. Close | 33.11 |
| Today's Range | 31.48 - 33.75 |
| 52wk Range | 22.96 - 43.15 |
| Shares Outstanding | 99,581,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Viking Therapeutics Q2 Earnings Call Highlights ↗
July 29, 2026
This GLP-1 Stock Could Double by 2030. Here's Why ↗
July 16, 2026
Should You Buy Eli Lilly Stock? Here's My Honest Take. ↗
July 11, 2026
Is This Biotech Stock a Buy After Its Massive Rally? ↗
July 09, 2026
Is It Too Late to Buy Eli Lilly? ↗
July 08, 2026
Is Viking Therapeutics Stock Going to $100? ↗
July 01, 2026
Frequently Asked Questions
Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 31.74
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 07/31/26 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.16B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.